MEDICARE'S DELAYED APPROVAL FOR OUTPATIENT JOINT REPLACEMENTS:

The Real Story.

Changes in healthcare policy often move at a glacial pace.

A prime example is Medicare's recent shift in stance on outpatient joint replacements. While commercial insurers had been covering total knee and hip replacements in ambulatory surgery centers (ASCs) since around 2010,

Medicare only approved these procedures for outpatient settings in 2018 and 2020, respectively. This delay, spanning nearly a decade, raises important questions about Medicare's priorities and decision-making processes.

The Timeline

- By 2012, Many commercial payers had already approved total knee and hip replacements in ASCs.

- 2018: Medicare finally approved total knee replacements in outpatient centers.

- 2020: Medicare-approved total hip replacements in outpatient settings.

The Real Reasons Behind the Delay

Contrary to what many might assume, the primary factors behind this delay were unrelated to patient safety or quality of care. Instead, the delay appears to have been driven by institutional and financial interests:

1. Support for Hospitals

The most significant factor in Medicare's delay was its long-standing hospital support policy. Medicare has a history of paying hospitals significantly more than private practices - often 2 to 10 times as much for the same procedures. This preferential treatment has been critical in consolidating private practices into larger health systems.

2. Encouraging Consolidation

For over two decades, Medicare has implemented policies that have forced or encouraged the consolidation of private practices into health systems. This delay in approving outpatient joint replacements aligns with this broader strategy, as it kept these lucrative procedures within hospital settings longer.

3. Regulatory Process

While the regulatory process did contribute to the delay, it was not the primary factor. The lengthy review and approval process, including public comment periods and stakeholder input, provided a convenient excuse for maintaining the status quo.

4. Institutional Priorities

Contrary to its public image, Medicare as an agency is not primarily focused on patient care. Instead, its priorities often revolve around managing budget dollars, maintaining and expanding its power and influence, and preserving jobs within the healthcare bureaucracy.

Implications of the Delay

The consequences of this delay were significant:

- Higher Prices: By keeping joint replacements in inpatient settings, Medicare ensured higher hospital reimbursements, increasing costs for both the program and patients.

- Limited Access: Medicare beneficiaries had fewer options for joint replacements, potentially leading to longer wait times or travel distances for procedures.

- Slowed Innovation: The delay slowed the shift towards more efficient outpatient procedures in orthopedic care.

Looking Ahead

We expect to see some changes since Medicare has finally approved outpatient total knee and hip replacements. However, it's essential to view these developments with a critical eye:

- Increased access to outpatient procedures for Medicare beneficiaries.

- Continued tension between established healthcare institutions and more efficient care models.

This case is a stark reminder of healthcare policy's complex and often misaligned incentives.

It emphasizes the many reasons physicians ought to come together to advocate in Washington.

It highlights the need for increased transparency in decision-making processes and a reevaluation of Medicare's role in shaping the healthcare landscape.

Patients, physicians, and policymakers must push for reforms prioritizing efficient, cost-effective care over institutional interests as we progress.

Only by acknowledging and addressing these systemic issues can we create a healthcare system that truly serves patients' needs.

-Rojas out